West Pharma’s financial strength is solid, and the firm has historically managed a very strong balance sheet. As of year-end 2023, West had total debt outstanding of $206 million. West has ...

Routine cleanings and check-ups are generally affordable, but the costs can rise significantly if your pet needs more ...

Stuart Piltch, president of Risk Strategies Consulting and a seasoned expert in healthcare and insurance, offers his ...

The company saw big bills related to cancer, premature births and hospital prices driving up claim severity in the fourth ...

California Gov. Gavin Newsom and state legislators in Sacramento seem to agree: Prescription drug prices are too high. But ...

In the absence of strong state and federal regulations, some suburbs have banned the sale of hemp products that get users ...

Novartis' strong drug pipeline and financials support an 11% annual return by 2027. Learn why NVS stock offers 33% return ...

Polypharmacy, biosimilars, and GLP-1s among the evolving trends likely to play out in the pharmacy benefits space.

As demand remains high for GLP-1 drugs, primary care physicians are concerned about the risks of patients using third-party ...

New cancer treatments are proving effective, but expensive, impacting overall healthcare expenditures. Researcher says reimbursements could be made conditional on reaching endpoints.

If you’re considering enrolling in a Medicare Supplement plan in California to meet your health insurance needs, you’re not ...

The impact will be crippling to biomedical research in the U.S., and institutions will immediately face hard choices about ...